Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection

Int J Mol Sci. 2022 Sep 3;23(17):10106. doi: 10.3390/ijms231710106.

Abstract

Background: Kawasaki Disease (KD) and Multisystem Inflammatory Syndrome in Children (MIS-C) are pediatric diseases characterized by systemic inflammation and vascular injury, potentially leading to coronary artery lesions (CALs). Data on vascular injury occurring during acute COVID-19 (AC19) in children are still lacking. The aim of our study was to investigate endothelial injury in KD-, MIS-C- and AC19-dosing circulating endothelial cells (CECs).

Methods: We conducted a multicenter prospective study. CECs were enumerated by CellSearch technology through the immunomagnetic capture of CD146-positive cells from whole blood.

Results: We enrolled 9 KD, 20 MIS-C and 10 AC19. During the acute stage, the AC19 and KD patients had higher CECs levels than the MIS-C patients. From the acute to subacute phase, a significant CEC increase was observed in the KD patients, while a mild decrease was detected in the MIS-C patients. Cellular clusters/syncytia were more common in the KD patients. No correlation between CECs and CALs were found in the MIS-C patients. The incidence of CALs in the KD group was too low to investigate this correlation.

Conclusions: Our study suggests a possible role of CECs as biomarkers of systemic inflammation and endothelial dysfunction in KD and MIS-C and different mechanisms of vascular injury in these diseases. Further larger studies are needed.

Keywords: COVID-19; CellSearch; children; circulating endothelial cells; coronary artery lesions; endothelial injury; kawasaki disease; multisystem inflammatory syndrome in children.

Publication types

  • Multicenter Study

MeSH terms

  • Biomarkers
  • COVID-19* / complications
  • Child
  • Endothelial Cells / pathology
  • Humans
  • Mucocutaneous Lymph Node Syndrome* / complications
  • Mucocutaneous Lymph Node Syndrome* / diagnosis
  • Prospective Studies
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / complications
  • Systemic Inflammatory Response Syndrome / diagnosis
  • Vascular System Injuries*

Substances

  • Biomarkers

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related

Grants and funding

This research received no external funding.